Results 51 to 60 of about 10,629 (179)
Cysteamine selectively enhances neuropeptide Y2 receptor binding activity
, 1992 Affinity labeling of [125I]NPY to the bovine hippocampal NPY receptor has revealed a 50 kDa specific binding protein, the Y2 receptor. Cysteamine (10 μM – 10 mM) specifically enhanced NPY specific labeling of the Y2 receptor without affecting ...
Li, Wei, Hexum, Terry D
core +1 more source
Brunner's glands of the rat during cysteamine ulceration
, 1981 Duodenal ulcers can be produced in rats by subcutaneous administration of cysteamine-HCl. The pathogenesis of these ulcers has not been fully explained. Increased acid secretion is necessary but not sufficient for ulcer production.
Poulsen, Steen Seier
core
, 2016 In this study, the protective effects of cysteamine, putrescine, and the combination of cysteamine and putrescine were investigated in mice with fibrosarcoma induced with 3-methylcholanthrene (3-MC).
Erdağ D. +11 more
core +1 more source
Effect of cysteamine on serum enzymes and creatinine levels.
, 2012 Tumor bearing mice were treated with increasing doses of cysteamine and serum was collected from tail veins twice, i.e., pre-cysteamine treatment (day 4) and post- treatment (day 18).
Benjamin Rubin (169516) +6 more
core +1 more source
, 2018 Achini K Makuloluwa, Fatemeh Shams Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK Abstract: Cystinosis is a rare, autosomal recessive disorder leading to defective transport of cystine out of lysosomes.
Makuloluwa AK, Shams F
core
Cysteamine 에 의한 세포사멸, ER 스트레스, 그리고 염증반응의 조절 기전
, 2021 학위논문 (박사) -- 서울대학교 대학원 : 의과대학 의과학과, 2021. 2. 김인규.시스티아민은 Coenzyme A 분해과정에서 생성되는 thiolamine으로 세포내에서 PKC1, Transglutaminase 2 (TG2), caspase 3의 효소활성을 억제한다.
이진행
core
Antioxidant effect of cysteamine in brain cortex of young rats
, 2008 Cysteamine is a cystine-depleting drug used in the treatment of cystinosis, a metabolic disorder caused by deficiency of the lysosomal cystine carrier.
Biasibetti, Micheli +6 more
core
Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
, 2021 A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly
A. Maroni +3 more
core
The mechanism of gastrin release in cysteamine-induced duodenal ulcer
, 1982 Duodenal ulcer can be induced in rats by a single dose of cysteamine. The ulcer formation is accompanied by acid hypersecretion and elevated serum gastrin levels.
Poulsen, Steen Seier
core
Clinical Efficacy of Cysteamine Application for Melasma: A Meta-Analysis
Background: Melasma is a challenging, acquired hyperpigmentary disorder. The gold standard treatment is Kligman’s formulation, which contains hydroquinone, tretinoin, and dexamethasone, but its long-term use is limited by the risk of exogenous ...
Tzong-Yuan Juang +5 more
core +1 more source